Regulation Of Protein Function Flashcards

1
Q

Name methods of short term regulation

A
  1. Substrate and product concentration
  2. Change in enzyme conformation
    A. Allosteric regulation
    B. Covalent modification
    C. Proteolytic cleavage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name methods of long term regulation

A

LONG TERM REGULATION

  1. Change in rate of protein synthesis
  2. Change in rate of protein degradation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the easiest way of controlling enzyme activity?

A

Changing substrate concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are isoenzymes?

A

Different forms of the same enzyme that have different kinetic properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is product inhibition?

A

Accumulation of the product of a relation inhibits the forward reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give an example of end product inhibition

A

Glucose-6-phosphate inhibits hexokinase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the shape of the rate/substrate conc graph shown by a simple enzyme

A

Rectangular hyperbola

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the shape of the rate/substrate conc graph shown by an allosteric enzyme

A

Sigmoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How many states can multisubunit enzymes exist in? What are these states?

A

2 conformations
T state - low affinity
R state - high affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is positive cooperativity?

A

Substrate binding to one subunit makes subsequence binding to other subunits progressively easier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

WHat do allosteric activators do?

A

Increase the proportion of the enzyme in the R state - rate then increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do allosteric inhibitors do?

A

Increase the proportion of the enzyme in the T state - rate then decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the function of phosphpfruktokinase?

A

Sets the pace of glycolysis and is allosterically regulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does ATP inhibit or activate PFK? Explain.

A

ATP in low concs is a substrate
In high concs is an inhibitor which stabilises the T state - as if enough atp is present, glycolysis does not need to take place (as quickly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Does AMP inhibit or activate PFK? Explain.

A

AMP is a low energy signal
When a cell is very low on ATP it will start converting ADP (ADP+ADP->ATP+AMP)
High levels of AMP means ATP is low
Therefore AMP stabilises R state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Does citrate inhibit or activate PFK? Explain.

A

Citrate is a high energy signal
It is the first product of the Krebs cycle. If it builds up this is a signal that glycolysis can slow down
Therefore stabilises t state - inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Does H+ inhibit or activate PFK? Explain.

A

H+ is a product - high concentrations is a high energy signal so high concs stabilise the t state

18
Q

Is fructose-2,6-bisphosphate an activator or inhibitor of PFK?

A

PFK 2 makes this
But it binds to PFK 1 and stabilises the R state
Activator

19
Q

What is the function of protein kinases?

A

Transfer the terminal phosphate from ATP to the -OH group of Ser, Thr, Tyr
Covalent addition

20
Q

What is the function of protein phosphatases?

A

Reverse the effects of protein kinases by catalysing the hydrolysis removal of phosphoryl groups from proteins
This can increase of decrease activity

21
Q

Why is protein phosphorylation so effective?

A

Adds 2 negative charges
A phosphoryl group can make H-bonds
Rate of phosphorylation/dephosphorylation can be adjusted
Links energy status of the cell to metabolism through ATP
Allow for amplification effects
How does this have an affect of a protein?
-ve charge - big effect on protein structure
Allows protein to make additional hydrogen bonds
We can regulate rate of phosphorylation/dephosphoylation

22
Q

Describe amplification by enzyme cascades

A

When enzymes activate enzymes, the number of affected molecules increases geometrically in an enzyme cascade
Amplification of signals by kinase cascades allows amplification of the initial signal by several orders of magnitude within a few milliseconds

23
Q

Name some enzymes which are activated by specific proteolytic cleavage

A

Specific proteolysis is a common means of activating enzymes in biological systems. For example:
1. Digestive enzymes are synthesized as zymogens (inactive precursors) in the stomach and pancreas.
2. Some protein hormones (e.g. insulin) are synthesised as inactive
precursors.
3. Blood clotting is mediated by a cascade of proteolytic activations that ensures a rapid and amplified response.
4. Many developmental processes are controlled by the activation of zymogens to contribute to tissue remodelling.
5. Programmed cell death (apoptosis) is mediated by proteolytic
enzymes, caspases, which are synthesised in inactive (procaspase) form.

24
Q

What are zymogens?

A

Inactive precursors of enzymes

25
Q

Give some examples of zymogens

A
Pepsinogen - stomach 
Chymotrypsinogen - pancreas
Trypsinogen - pancreas
Proelastase - pancreas
Procarboxypeptidase - pancreas
26
Q

What is the function of endogenous inhibitors?

A

Regulate protease activity e.g.pancreatic trypsin inhibitor binds trypsin ans stops activity

27
Q

What causes emphysema?

A

Deficiency of alpha1-antitrypsin, destruction of alveolar walls by elastase

alpha1-antitrypsin - plasma protein that inhibits a range of proteases

28
Q

What are the 2 pathways to start the blood clotting cascade?

A

Intrinsic pathway - damaged endothelial lining of blood cells promotes binding of factor XII
Membrane damage plays a role in activation of the intrinsic pathway
• Factor IX and X are targeted to membrane by Gla domains
• Ca2+ plays a role
• required for sustained thrombin activation

Extrinsic pathway - Trauma releases tissue factor III - Membrane damage exposes extracelluar domain of tissue (factor III) Auotcatalytic activation of Factor VII

Factor X is the common endpoint for both pathways

29
Q

What does factor X activation lead to?

A

Thrombin activation then formation of fibrin clot

30
Q

Why is a cascade beneficial?

A

Allows formation of clot from activation of very small amounts of the initial factor

31
Q

Describe the modular structure or prothrombin

A

Gla domain - Kringle - Kringle - - serine protease

32
Q

Where is the protease function of prothrombin?

A

C-terminal domain

33
Q

What is he function of the Kringle domains?

A

Help keep prothrombin in the inactive form

34
Q

What is the purpose of the gla domains?

A

Target prothrombin to appropriate sites for activation

Gla = carboxy glutamate

35
Q

What happens when prothrombin is activated?

A

Releases active serine protease

36
Q

Describe the role of gla domains

A

Post-translational modification of factors II, VII, IX, X in the liver
• Addition of COOH groups to glutamate residues to form carboxyglutamate (Gla)
• Allows interaction with sites of damage and brings together clotting factors

In a damages blood vessels there are exposed phospholipids - Ca2+ binds to site of damage
Gla residues have COO-so are -ve charged so attracted by Ca2+
Clotting factors contain gla domains so are attracted to site of damage - if theyre closer together they work faster
Only prothrombin next to site of damage will be activated so clots will be localised to the site of damage

37
Q

Describe the structure of fibrinogen

A

340kDa protein
• 2 sets of tripeptides , a, b, g, joined at N-termini by disulphide bonds
• 3 globular domains linked by rods
N-terminal regions of a and b chains are highly negatively charged and prevent aggregation of fibrinogen

38
Q

Describe the formation of a fibrin clot

A

(1) Thrombin cleaves fibrinopeptides A and B from the central globular
domain of fibrinogen.
(2) Globular domains at the C-terminal ends of the b and g chains interact with exposed sequences at the N-termini of the cleaved b and a chains to form a fibrin mesh or clot.
The newly formed clot is stabilised by the formation of amide bonds between the side chains of lysine and glutamine residues in different monomers.
This cross-linking reaction is catalysed by transglutaminase, which is activated from protransglutaminase by thrombin.

39
Q

What is haemophilia

A

Defect in factor VIII
- Factor VIII (‘antihaemophilic factor’) is not a protease, but markedly
stimulates the activity of factor IX, a serine protease.
- The activity of factor VIII is markedly increased by limited proteolysis by thrombin and factor Xa. This positive feedback amplifies the clotting signal and accelerates clot formation.
- Treatment with recombinant factor VIII

40
Q

How is the clotting process stopped?

A
  1. Localisation of (pro)thrombin - Dilution of clotting factors by blood flow, and removal by liver
  2. Digestion by proteases - for example, factors Va and VIIIa are degraded by protein C
    - protein C is activated by thrombin binding to endothelial receptor, thrombomodulin
    - defects in protein C can cause thrombotic disease
41
Q

How is the clotting process regulated?

A

Inhibitors stop clotting progress
Heparin binds to form tight complex - blocks thrombin activity

3. Specific inhibitors
Antithrombin III (AT3)
Enhanced by heparin binding
AT3-heparin does not act on
thrombomodulin-bound thrombin
42
Q

Give an overview of the key points in blood clotting

A
  1. Inactive zymogens present at low concentration.
  2. Proteolytic activation.
  3. Amplification of initial signal by cascade mechanism.
  4. Clustering of clotting factors at site of damage.
  5. Feedback activation by thrombin ensures continuation of clotting.
  6. Termination of clotting by multiple mechanisms.
  7. Clot breakdown controlled by proteolytic activation.